177lu-psma-617
novartis
['crpc', 'vision trial']
tumor dosimetry of lupsma for mcrpc: vision trial sub-study 29 pts, 104 tumors mean radiation-abs dose 6.5 gy/gbq med abs dose 4.4 gy/gbq 6-cycle cumulative estimate abs dose for all tumors: 287 gy #asco23 
Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor